G. A. Camacho-Hernandez

Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice

A. Newman, A. Gianoncelli, G. Ribaudo, 2022, Pharmaceutics.

Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram.

H. Sitte, G. Schütz, A. Newman, 2021, RSC medicinal chemistry.

Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.

L. Pardo, S. Ferré, Alessandro Bonifazi, 2022, Pharmacological research.

Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux

H. Sitte, M. Brameshuber, G. Schütz, 2022, Communications Biology.

Synthesis, pharmacological characterization, and structure-activity relationships of non-canonical selective agonists for α7 nAChRs.

R. Papke, P. Taylor, B. Duggan, 2019, Journal of medicinal chemistry.

Synaptic-like axo-axonal transmission from striatal cholinergic interneurons onto dopaminergic fibers

B. Averbeck, Zayd M. Khaliq, M. Eldridge, 2022, Neuron.

Differential Activation and Desensitization States Promoted by Noncanonical α7 Nicotinic Acetylcholine Receptor Agonists

R. Papke, Xiaoxuan Wu, C. Stokes, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure.

P. Taylor, Z. Kovarik, Z. Radić, 2019, Chemico-biological interactions.

Lessons from nature: Structural studies and drug design driven by a homologous surrogate from invertebrates, AChBP

P. Taylor, G. A. Camacho-Hernandez, G. Camacho-Hernandez, 2020, Neuropharmacology.